SCHEMBL15577892

SCHEMBL15577892

CCONC(=N)c1ccc(NCC(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
RAB9A P51151 4/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
AGTR1 P30556 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PRSS1 P07477 4/20 0.37
CA1 P00915 5/20 0.37
CA2 P00918 5/20 0.37
CA12 O43570 4/20 0.37
CA9 Q16790 3/20 0.37
CA7 P43166 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6370923 0.78 ITGB3 (0.43) ALDH1A1RAB9ANPC1HPGDAGTR1
SCHEMBL18033882 0.78 ALDH1A1 (0.42) ALDH1A1RAB9ANPC1HPGDAGTR1
SCHEMBL2525700 0.76 PRSS1 (0.62) ITGB3ITGA2BPRSS1F2
SCHEMBL5692310 0.73 ALDH1A1 (0.44) ALDH1A1RAB9ANPC1HPGDAGTR1
SCHEMBL11718244 0.73 RAB9A (0.71) ALDH1A1RAB9ANPC1HPGDAGTR1
SCHEMBL8639589 0.72 L3MBTL1 (0.46) ALDH1A1RAB9ANPC1HPGDAGTR1
SCHEMBL8637256 0.72 MAPT (0.52) ALDH1A1RAB9ANPC1HPGDAGTR1
Phosphonic Acid SCHEMBL15485473 0.72 PRSS1 (0.57) ITGB3ITGA2BPRSS1F2
SCHEMBL29051542 0.71 ALDH1A1 (0.46) ALDH1A1RAB9ANPC1HPGDAGTR1
SCHEMBL28670574 0.71 LMNA (0.50) ALDH1A1RAB9ANPC1HPGDAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014041559-A2 PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE AND INTERMEDIATES THEREOF GLENMARK PHARMACEUTICALS LIMITED; GLENMARK GENERICS LIMITED (IN) 2014-03-20 WO disclosed